INanoBio Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Private

  • Employees
  • 17

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $1.6M

  • Investors
  • 2

INanoBio General Information

Description

Operator of a biotechnology and early-stage disease diagnostics company intended to develop a 3D field-effect nanopore transistor device for sequencing the whole human genome. The company's device is based on CMOS semiconductor nanotechnology and is able to discover disease-specific molecular biomarkers and detect them in blood with high sensitivity, thereby enabling medical professionals to access nano-biotechnology tools to perform genomic analysis with better accuracy and lesser time and costs.

Contact Information

Website
www.inanobio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Drug Discovery
Biotechnology
Primary Office
  • 7201 East Henkel Way
  • Suite 285
  • Scottsdale, AZ 85255
  • United States
+1 (650) 000-0000

INanoBio Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

INanoBio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Seed Round 23-Dec-2020 $1.6M 00.00 Completed Product Development
10. Grant 05-Sep-2020 00000 00.000 Completed Product Development
9. Debt - PPP 28-Apr-2020 00.000 Completed Product Development
8. Seed Round 06-Feb-2020 00.00 00.000 Completed Product Development
7. Grant 30-Sep-2019 00000 00.000 Completed Product Development
6. Grant 01-Apr-2019 00.00 00.000 Completed Product Development
5. Seed Round 09-Oct-2018 000 00.000 Completed Product Development
4. Angel (individual) 22-Jun-2017 00000 Completed Startup
3. Angel (individual) 05-Apr-2016 $427K $427K Completed Product Development
2. Grant 05-Jan-2012 $330K Completed Startup
To view INanoBio’s complete valuation and funding history, request access »

INanoBio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biotechnology and early-stage disease diagnostics company intended to develop a 3D field-effect nanopore t
Diagnostic Equipment
Scottsdale, AZ
17 As of 2023
00.00
000000000 00.00

000000

lum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proid
0000000000 000000000
San Diego, CA
0000 As of 0000
00.000
0000 00.000

000000

m dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt
0000000000 000000000
Oxford, United Kingdom
0000 As of 0000
00.000
000000000 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

INanoBio Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Illumina Formerly VC-backed San Diego, CA 0000 00.000 0000 00.000
000000 00000000 00 Formerly VC-backed Oxford, United Kingdom 0000 00.000 000000000 00.000
0000000 0000000000 Formerly VC-backed Menlo Park, CA 000 00000 000000000 00000
You’re viewing 3 of 3 competitors. Get the full list »

INanoBio Patents

  • 12

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 4

    Granted

  • 7

    Pending

  • 000

    Expiring in next 12 mo

INanoBio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200386751-A1 Field effect transistor sensor detection assays and systems and methods of making and using same Inactive 28-Nov-2017 000000000000
EP-3717909-A1 Field effect transistor sensor detection assays and systems and methods of making and using same Pending 28-Nov-2017 000000000000
EP-3717909-A4 Field effect transistor sensor detection assays and systems and methods of making and using same Pending 28-Nov-2017 000000000000 0
EP-3698136-A1 Disease proteome protein arrays and uses thereof Pending 16-Oct-2017 000000000000
US-20200309773-A1 Disease proteome protein arrays and uses thereof Pending 16-Oct-2017 G01N33/54366 0
To view INanoBio’s complete patent history, request access »

INanoBio Executive Team (7)

Name Title Board Seat Contact Info
Bharath Takulapalli Ph.D Co-Founder & Chief Executive Officer
Mukilan Mohan Co-Founder, Chief Operating Officer & Board Member
Joshua LaBaer Ph.D Member of Scientific Advisory Board
Thomas Hoster Consulting Chief Financial Officer
Chenming Hu Ph.D Member of Scientific Advisory Board
You’re viewing 5 of 7 executive team members. Get the full list »

INanoBio Board Members (5)

Name Representing Role Since
Abhay Sanan MD Self Board Member & Scientific Advisor 000 0000
George Church Ph.D Self Chairman of Scientific Advisory Board 000 0000
George Poste Ph.D Self Board Member & Scientific Advisor 000 0000
Jean-Pierre Millon Self Board Member 000 0000
Mukilan Mohan INanoBio Co-Founder, Chief Operating Officer & Board Member 000 0000
To view INanoBio’s complete board members history, request access »

INanoBio Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

INanoBio Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Institutes of Health Government 000 0000 000000 0
The National Human Genome Research Institute Government 000 0000 000000 0
To view INanoBio’s complete investors history, request access »

Ready to get started?

Request a free trial